Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
New Therapy to Treat Advanced Small Cell Lung Cancer Approved for Australian Patients 2021-09-14 18:57
PharmAbcine to Participate in ACCESS CHINA Biotech Forum 2021-09-13 20:00
Samsung Biologics Joins Frontier 1.5D Project as part of 2050 Carbon Neutral Initiative 2021-09-13 12:41
PharmAbcine Announces Joint Patent Application with MSD for the Treatment of Cancer 2021-09-09 20:00
China's Northernmost Free Trade Zone Sees Wider Reform and Opening-up 2021-09-09 18:06
Biokangtai: Recombinant COVID-19 Vaccine(Adenovirus Vector) licensed for manufacturing, which actively promotes vaccine export and improves vaccine accessibility 2021-09-09 11:40
The Valens Company Achieves Access to GMP Manufacturing in Australia & Expands International Footprint to Asia-Pacific through Exclusive Partnership with Epsilon Healthcare 2021-09-08 19:00
Stem Cells for Everyone: I Peace expands its clinical-grade iPSC banking service leveraging mass manufacturing capability 2021-09-08 02:00
Peijia Medical Engages Professor Saibal Kar as Exclusive Consultant 2021-09-06 13:44
GeneQuantum and BrighGene sign agreement for development of antibody immune agonist conjugates 2021-09-06 09:00
AffaMed Therapeutics Enters into Strategic Partnership Agreement with Beijing Tiantan Hospital and Infinite Brain Technologies to Promote Digital Therapy in Neurological Diseases 2021-09-06 08:00
WuXi AppTec Receives AA ESG Rating from MSCI 2021-09-06 08:00
PharmAbcine Receives HREC Clearance for Phase II Trial of Olinvacimab and Pembrolizumab in mTNBC 2021-09-03 20:00
Arctic Vision Obtains China IND Clearance for Phase III Study of ARVN003, the First in China for Presbyopia Treatment 2021-09-03 08:00
Clinical trial provides preliminary evidence of a cure for myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS) and Long Covid 2021-09-03 06:00
I-Mab Added to FTSE Russell Global Equity Index Series 2021-09-02 20:00
ETERN Therapeutics Announces Completion of Series B Financing to Advance the Protein Liquid-Liquid Phase Separation Technology Platform and Accelerate the Development of Novel Drugs to Target "Undruggable" Proteins 2021-09-01 10:00
Deebio's Global Bio-enzyme Journey: 27 Years, 30 Countries and Regions 2021-08-31 19:46
Senhwa's Silmitasertib, COVID-19 Drug Candidate, Receives Positive Interim Review from Data Monitoring Committee to Proceed 2021-08-31 19:00
I-Mab Provides Business and Corporate Updates and Reports Financial Results for the Six Months Ended June 30, 2021 2021-08-31 18:00
1 100 101 102 103 104 222